The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

Chrna7  -  cholinergic receptor, nicotinic, alpha 7...

Rattus norvegicus

Synonyms: Acra7, BTX, NARAD, Neuronal acetylcholine receptor subunit alpha-7, nAChRa7
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Chrna7

  • Intramuscular injection of botulinum toxin type A (BTX) is used to treat many disorders characterized by muscular spasms [1].
  • A kinetic analysis of changes in BTX binding, performed 2 days following brain injury, indicated that the binding deficits are not due to significant changes in receptor affinity [2].
  • Botulism is a generalized paralyzing disease caused by the toxin of Clostridium botulinum (BTX) [3].
  • The clinical utility of using BTX to treat overactive bladder syndromes and bladder hypersensory states, especially those that may be caused by an augmentation of the purinergic pathway, should be studied further [4].
  • Small quantities of botulinum toxin (BTX) are useful in the treatment of certain movement disorders, such as laryngeal spasmodic dysphonia, blepharospasm, and cervical dystonia [5].
 

High impact information on Chrna7

  • The effect of extracellular Ca2+ concentration and myasthenic globulin on the distribution and appearance of acetylcholine receptor (AChR) clusters on rat myotubes was studied with tetramethyl-rhodamine-labeled alpha BTX [6].
  • In competition binding experiments, alpha BTX, curare, nicotine, and quinacrine were the most potent competitors [7].
  • Acetylcholine competed with 125I-alpha BTX binding at 2 sites with estimated affinities of 3.6 X 10(-8) and 7.4 X 10(-5) M [7].
  • When binding of 125I-alpha bungarotoxin (125I-alpha BTX) to hypothalamic membranes is observed over a wide range of concentrations, 3 binding sites can be identified, with estimated equilibrium dissociation constants (Kds) of 4.1 X 10(-11) M, 6.2 X 10(-10) M, and 9.1 X 10(-7) M for high-, low-, and very-low-affinity interactions, respectively [7].
  • In the rostral hypothalamus, high-affinity binding of 125I-alpha BTX was localized to the region of the supraoptic nucleus, paraventricular nucleus, suprachiasmatic nucleus, and the nucleus circularis complex [7].
 

Biological context of Chrna7

  • There was no clear evidence that stimulation of sites in the medial part of disconnected vibrissa-cortex evoked eye movements during the first 6 days after BTX injection [8].
  • The compound muscle action potential (MAP) of the vibrissae muscle began to reappear 4 weeks after the first BTX injection [9].
 

Anatomical context of Chrna7

  • Various lines of evidence suggest that the high affinity agonist-binding sites in brain correspond to nicotinic cholinergic receptors similar to those found at autonomic ganglia; BTX-binding sites may also serve as receptors for nicotine and are possibly related to neuromuscular nicotinic cholinoceptors [10].
  • Transcainide, a complex derivative of lidocaine, blocks the open state of BTX-activated sodium channels from bovine heart and rat skeletal muscle in two distinct ways [11].
  • 6. At normal [Ca2+]o and [Mg2+]o, the depression of EPP amplitude during stimulation of the phrenic nerve at 30-50 Hz was somewhat larger at endplates from alpha BTX-treated rats than at control endplates [12].
  • To this end a transitory flaccid paralysis of the vibrissae muscle was induced in adult rats that underwent two unilateral injections of 8 U of botulinum toxin (BTX) into a vibrissal pad, at a duration of 12 days from one another [9].
  • Brain injury caused significant decreases in BTX binding in several regions of the hippocampus [13].
 

Associations of Chrna7 with chemical compounds

  • 3. In vitro application of the Ca2+ channel blockers nifedipine (10 microM) or omega-conotoxin (40 nM) had no significant effect on the increased quantal content of endplates from alpha BTX-treated rats [12].
  • 4. At control endplates, in vitro block of presynaptic K+ channels by 5 microM 3,4-diaminopyridine did increase the quantal content to a level which was similar to that found in endplates of alpha BTX-treated rats but also induced a broadening of EPPs, which was not found at endplates after alpha BTX treatment [12].
  • Lifarizine displaced [3H]-batrachotoxinin-A 20-alpha-benzoate (BTX) binding with moderate affinity (pIC50 7.31 +/- 0.24) indicating an interaction with toxin site 2 [14].
  • This hypothesis was tested by examining post mortem [3H]-nicotine and [125I]-alpha-bungarotoxin ([125I]-alpha BTX) binding following treatment in vivo with the quasi-irreversible and insurmountable CNS nicotinic blocker chlorisondamine, given either alone or in combination with chronic nicotine administration [15].
  • In contrast, changes in the density of alpha3/alpha4 nAChr's, muscarinic AChr's, NMDA-type glutamate receptors, and L-type calcium channel expression were more regionally restricted and lower in magnitude, as compared to changes in BTX binding [16].
 

Analytical, diagnostic and therapeutic context of Chrna7

  • In this study we have used alpha BTX conjugated to horseradish peroxidase (HRP) and quantitative electron microscopy to determine the intracellular pathway(s) of acetylcholine receptors during the internalization process [17].
  • Binding of the muscarinic cholinergic receptor probe [3H]quinuclidinylbenzilate ([3H]QNB) and the putative nicotinic receptor probe [125I]alpha-bungarotoxin ([125I]alpha BTX) to vasopressin (VP) and oxytocin (OT) neuroendocrine cells was investigated with a combination of quantitative receptor binding, autoradiography and immunocytochemistry [18].
  • OBJECTIVES: To assess the effects of intravesical injection of botulinum toxin type A (BTX) on a model of detrusor overactivity induced by intravesical infusions of adenosine triphosphate (ATP) and capsaicin [4].

References

  1. Skeletal muscle-specific immunotoxin for the treatment of focal muscle spasm. Hott, J.S., Dalakas, M.C., Sung, C., Hallett, M., Youle, R.J. Neurology (1998) [Pubmed]
  2. Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury. Verbois, S.L., Scheff, S.W., Pauly, J.R. J. Neurotrauma (2002) [Pubmed]
  3. Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin. Chappard, D., Chennebault, A., Moreau, M., Legrand, E., Audran, M., Basle, M.F. Bone (2001) [Pubmed]
  4. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model. Atiemo, H., Wynes, J., Chuo, J., Nipkow, L., Sklar, G.N., Chai, T.C. Urology (2005) [Pubmed]
  5. Association of adhesive macromolecules with terminal sprouts at the neuromuscular junction after botulinum treatment. Lee, R.E., Tartell, P.B., Karmody, C.S., Hunter, D.D. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. (1999) [Pubmed]
  6. Organization of acetylcholine receptor clusters in cultured rat myotubes is calcium dependent. Bursztajn, S., McManaman, J.L., Appel, S.H. J. Cell Biol. (1984) [Pubmed]
  7. Characteristics and distribution of high- and low-affinity alpha bungarotoxin binding sites in the rat hypothalamus. Meeker, R.B., Michels, K.M., Libber, M.T., Hayward, J.N. J. Neurosci. (1986) [Pubmed]
  8. Time course of motor cortex reorganization following botulinum toxin injection into the vibrissal pad of the adult rat. Franchi, G. Eur. J. Neurosci. (2002) [Pubmed]
  9. Time course for the reappearance of vibrissal motor representation following botulinum toxin injection into the vibrissal pad of the adult rat. Franchi, G., Veronesi, C. Eur. J. Neurosci. (2004) [Pubmed]
  10. Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. Clarke, P.B., Schwartz, R.D., Paul, S.M., Pert, C.B., Pert, A. J. Neurosci. (1985) [Pubmed]
  11. Transcainide causes two modes of open-channel block with different voltage sensitivities in batrachotoxin-activated sodium channels. Zamponi, G.W., French, R.J. Biophys. J. (1994) [Pubmed]
  12. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium. Plomp, J.J., van Kempen, G.T., Molenaar, P.C. J. Physiol. (Lond.) (1994) [Pubmed]
  13. Chronic nicotine treatment attenuates alpha 7 nicotinic receptor deficits following traumatic brain injury. Verbois, S.L., Scheff, S.W., Pauly, J.R. Neuropharmacology (2003) [Pubmed]
  14. [3H]-lifarizine, a high affinity probe for inactivated sodium channels. MacKinnon, A.C., Wyatt, K.M., McGivern, J.G., Sheridan, R.D., Brown, C.M. Br. J. Pharmacol. (1995) [Pubmed]
  15. Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine. el-Bizri, H., Clarke, P.B. Br. J. Pharmacol. (1994) [Pubmed]
  16. Traumatic brain injury reduces hippocampal alpha7 nicotinic cholinergic receptor binding. Verbois, S.L., Sullivan, P.G., Scheff, S.W., Pauly, J.R. J. Neurotrauma (2000) [Pubmed]
  17. Coated and smooth vesicles participate in acetylcholine receptor transport. Bursztajn, S., Nudleman, H.B., Berman, S.A. Cell Tissue Res. (1987) [Pubmed]
  18. Differential distribution of muscarinic cholinergic and putative nicotinic cholinergic receptors within the hypothalamo-neurohypophysial system of the rat. Michels, K.M., Meeker, R.B., Hayward, J.N. Neuroendocrinology (1986) [Pubmed]
 
WikiGenes - Universities